Showing results (41-50 of 183) with videos related to

Sort By:
Pageof 19
Advances in Therapy|November 28, 2015
Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by AgeSandra M Swain, Raquel Nunes, Carl Yoshizawa, et al.
Contemporary Clinical Trials Communications|August 4, 2017
Focus on You: Cancer clinical trials perspectivesBrandi N Robinson, Antoinette F Newman, Sherrie F Wallington, et al.
The Breast Journal|March 11, 2004
CA 125 elevation in breast cancer: a case report and review of the literatureGregory D Leonard, Jennifer A Low, Arlene W Berman, et al.
Texas Heart Institute Journal|July 2, 2011
Cardiac dysfunction after cancer treatmentMichael S Ewer, Sandra M Swain, Daniela Cardinale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Gene expression patterns and profile changes pre- and post-erlotinib treatment in patients with metastatic breast cancerSherry X Yang, Richard M Simon, Antoinette R Tan, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 14, 2003
Liquid-chromatographic determination of erlotinib (OSI-774), an epidermal growth factor receptor tyrosine kinase inhibitorErin R Lepper, Sandra M Swain, Antoinette R Tan, et al.
Journal of Surgical Oncology|February 11, 2009
The influence of a gene expression profile on breast cancer decisionsLeonard R Henry, Alexander Stojadinovic, Sandra M Swain, et al.
Oncology Reports|January 5, 2007
Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarraySherry X Yang, Stephen M Hewitt, Seth M Steinberg, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
A critical review of the enrollment of black patients in cancer clinical trialsDeliya R Banda, Diane St Germain, Worta McCaskill-Stevens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Gene expression profile and angiogenic marker correlates with response to neoadjuvant bevacizumab followed by bevacizumab plus chemotherapy in breast cancerSherry X Yang, Seth M Steinberg, Dat Nguyen, et al.
Pageof 19